Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer’s disease patientsFederica Varsaldi, Grazia Lombardi, Laura Villa et al.|European Journal of Clinical Pharmacology|2006Cited by 96
Do CYP3A and ABCB1 genotypes influence the plasma concentration and clinical outcome of donepezil treatment?Laura Magliulo, Maria Gabriella Scordo, Marja‐Liisa Dahl et al.|European Journal of Clinical Pharmacology|2010Cited by 45